Hep A Pediatric, Vaqta® and MMR Pediatric, MMRII CDC Federal ContractNumber: 75D30125D00195, Manufacturer: Merck (MRK). Program, (Immunizations…

Merck Sharp & Dohme Corp has been awarded contract HHSTX-6-0000397146 by the State of Texas, effective March 11, 2026, to supply pediatric immunization vaccines under the Texas Immunizations, Vaccine Services Group program. The contract encompasses the provision of Hepatitis A Pediatric (Vaqta) and Measles, Mumps, and Rubella Pediatric (MMRII) vaccines, which are procured through the Centers for Disease Control and Prevention Federal Contract Number 75D30125D00195. The award is authorized under Texas Government Code Section 2155.144 and is classified under the National Institute of Governmental Purchasing (NIGP) category 26980 for Serums, Toxoids, and Vaccines.

The contract encompasses pharmaceutical products classified under multiple United Nations Standard Products and Services Code (UNSPSC) categories, including vaccine classifications and immunomodulating pharmaceutical agents. While specific contract values, annual amounts, and cumulative values are not provided in the award documentation, the contract represents a critical procurement for the State of Texas's pediatric vaccination program. The prime contractor will deliver these immunization products in accordance with federal Centers for Disease Control and Prevention standards and state requirements governing vaccine distribution and administration.